Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.

Ziegler D, Reljanovic M, Mehnert H, Gries FA.

Exp Clin Endocrinol Diabetes. 1999;107(7):421-30. Review.

PMID:
10595592
2.

Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.

Ziegler D.

Treat Endocrinol. 2004;3(3):173-89. Review.

PMID:
16026113
4.

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.

Ziegler D, Nowak H, Kempler P, Vargha P, Low PA.

Diabet Med. 2004 Feb;21(2):114-21.

PMID:
14984445
5.
6.
7.

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O'Brien PC, Reljanovic M, Samigullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D; SYDNEY Trial Study Group.

Diabetes Care. 2003 Mar;26(3):770-6. Erratum in: Diabetes Care. 2003 Jul;26(7):2227.

PMID:
12610036
8.

Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.

Ziegler D, Gries FA.

Diabetes. 1997 Sep;46 Suppl 2:S62-6. Review.

PMID:
9285502
9.

[Diabetic somatic polyneuropathy. Pathogenesis, clinical manifestations and therapeutic concepts].

Hilz MJ, Marthol H, Neundörfer B.

Fortschr Neurol Psychiatr. 2000 Jun;68(6):278-88. Review. German.

PMID:
10923253
10.
11.
12.

α-Lipoic acid, diabetic neuropathy, and Nathan's prophecy.

Papanas N, Maltezos E.

Angiology. 2012 Feb;63(2):81-3. doi: 10.1177/0003319711421165.

PMID:
22253286
13.

Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy.

Sachse G, Willms B.

Horm Metab Res Suppl. 1980;9:105-7.

PMID:
6769773
14.

Treatment of diabetic polyneuropathy: Update 2006.

Ziegler D.

Ann N Y Acad Sci. 2006 Nov;1084:250-66. Review.

PMID:
17151306
15.

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).

Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schütte K, Gries FA.

Diabetologia. 1995 Dec;38(12):1425-33.

PMID:
8786016
16.

The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy.

Haak ES, Usadel KH, Kohleisen M, Yilmaz A, Kusterer K, Haak T.

Microvasc Res. 1999 Jul;58(1):28-34.

PMID:
10388600
17.

Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.

Vereşiu IA.

Rom J Intern Med. 2004;42(2):293-9. Review.

PMID:
15529620
18.

Treatment of diabetic neuropathy and neuropathic pain: how far have we come?

Ziegler D.

Diabetes Care. 2008 Feb;31 Suppl 2:S255-61. doi: 10.2337/dc08-s263. Retraction in: Diabetes Care. 2012 Feb;35(2):456.

PMID:
18227494
19.

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R.

Diabetes Care. 2006 Nov;29(11):2365-70.

PMID:
17065669
20.
Items per page

Supplemental Content

Write to the Help Desk